Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1193 results for "sun pharma"

Ranbaxy buy in line with Sun's strategy

Sun Pharma's recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known for its turnaround talent. In fact, most buyouts by Sun, on ... Business Standard, 1 hour ago

516 images for sun pharma

India TV, 3 days ago
XinMsn, 3 days ago
Sify, 3 days ago
Financial Express, 1 week ago
Business Today India, 4 days ago
NDTV, 1 week ago
Financial Express, 1 week ago, 1 week ago, 1 week ago
NDTV, 1 week ago
Money Control

Stocks in news: Infy, AstraZeneca, United Spirits, Bharti

Infosys | DCB Bank | CMC | Gruh Finance | Tata Motors | Tata Power | AstraZeneca Pharma | United Spirits | Tata Steel | Coal India | Bharti Airtel | Ambuja Cements | SBI | NMDC | Zee Entertainment | Mindtree | Sun Pharma | Lupin | MCX and Zenotech ...
 Money Control1 day ago 22,715 new all-time closing high for Sensex  Economic Times6 days ago MM, ONGC, Sun Pharma weak; Nifty, Sensex rangebound  Money Control6 days ago Tata Motors surges 3%, pharma weak; Sensex, Nifty firm  Money Control6 days ago

Stocks in news: CMS, Tata Steel, Sun Pharma

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges . Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page . Quotes are updated ...
 Yahoo! India1 day ago

FIIs hike stake in Sun Pharma during March quarter

Foreign institutional investors (FIIs) have raised shareholding in Sun Pharmaceutical Industries, the leading pharmaceutical company. FIIs shareholding increased 2 basis points to 22.51% at the end of March 2014 quarter from 22.49% as on Dec. 31, ...
 MyIris1 day ago
Manorama Online

Sun-rise over Modi

The Sun Pharma-Daiichi Sankyo deal to buy Ranbaxy appears to have galvanised the Bharatiya Janata Party and its supporters to fashion a poll message linking it to the party's prime ministerial candidate Narendra Modi. A text message doing the rounds ...
 Business Standard6 days ago Sun Pharma (Buy)  Business Line1 week ago Sun Pharma to phase out Ranbaxy drugs in US  Manorama Online1 week ago Sun Pharma plans phasing out Ranbaxy drugs in U.S  Yahoo! UK and Ireland1 week ago
Business Standard

Premature to talk of changes in Ranbaxy management team now: Dilip Shanghvi & Israel Makov

Interview with Managing Director & Chairman, Sun Pharma Reghu Balakrishnan | Mumbai April 13, 2014 Last Updated at 23:39 IST Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management ...
 Business Standard3 days ago 'Premature to talk of changes in Ranbaxy top brass now'  Rediff.com2 days ago Newsmaker: Dilip Shanghvi  Business Standard6 days ago Sun Pharma-Ranbaxy deal: Well Guide Ranbaxy, says Dilip Shanghvi  Economic Times1 week ago

Ranbaxy buy triggers sun pharma's zenotech offer

04/15/2014 | 07:29am US/Eastern Recommend: 0 Sun Pharmaceutical Industries Ltd has offered to buy 28.1 percent of Zenotech Laboratories equity at Rs19 per share through an open offer. The move follows its acquisition of ...
 4 Traders1 day ago Sun Pharma to make Rs 18 cr...  Siasat Daily4 days ago Sun Pharma may acquire Zenotech laboratories limited  Deccan Chronicle4 days ago Sun Pharma makes open offer for Zenotech  VC Circle5 days ago
Finance 24

Investors back Sun Pharma's Ranbaxy move (AFP)

On the surface, Sun Pharma's $US3.2 billion ($A3.42 billion) purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. But Sun Pharmaceutical Industries' shares ...
 West Australian1 day ago Sun Pharma is able to revive Ranbaxy: investors  China Post2 days ago Investors hail Sun Pharma's Ranbaxy buy  Qatar Peninsula2 days ago 'Sun Pharma can nurse Ranbaxy to health'  Finance 243 days ago
Money Control

'Accumulate' Sun Pharma; target Rs 646: PL

Sun Pharmaceutical acquired Ranbaxy at an all-stock deal of USD 4 billion, including equity value of USD 3.2 billion and debt of USD 800 million. Per deal, Ranbaxy to merge with Sun Pharma at a stock swap ratio of 0.8:1. This implies 16% dilution in ...
 MyIris5 days ago Buy Sun Pharma with target price of Rs 625: Ashwani Gujral  Economic Times1 week ago Accumulate Sun Pharma; target of Rs 646: P Lilladher  Money Control5 days ago Buy Sun Pharma; target of Rs 661: Angel Broking  Money Control1 week ago
Financial Express

Ranbaxy Laboratories, Sun Pharma deal: Sebi looks for insiders

The Securities and Exchange Board of India (Sebi) is checking data relating to trades in Ranbaxy before Sun Pharma announced on Monday it was acquiring the Daiichi Sankyo-owned firm in an all-stock transaction, reports Jash Kriplani in Mumbai. There ...
 Financial Express6 days ago Sebi probing stock bounce before deal  The Financial Chronicle1 week ago Sun Ranbaxy in focus – SEBI might probe the deal  Money Control1 week ago Sun Pharma-Ranbaxy deal may come under Sebi scanner  Smart Investor1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less